Baby received, the seller shipped quickly, logistics is also very strong, customer service attitude is excellent, very patient, giving a kind of feeling, like it. There are also exquisite packaging, high-end atmosphere on the grade; it can be seen that the business is very attentive. Baby is really good. It's consistent with the picture. There's no difference. It's really worth more.
Linda
Baby received, the seller shipped quickly, logistics is also very strong, customer service attitude is excellent, very patient, giving a kind of feeling, like it. There are also exquisite packaging, high-end atmosphere on the grade; it can be seen that the business is very attentive. Baby is really good. It's consistent with the picture. There's no difference. It's really worth more.
Linda
Baby received, the seller shipped quickly, logistics is also very strong, customer service attitude is excellent, very patient, giving a kind of feeling, like it. There are also exquisite packaging, high-end atmosphere on the grade; it can be seen that the business is very attentive. Baby is really good. It's consistent with the picture. There's no difference. It's really worth more.
is a leading manufacturer of precision optical instruments and optical components in China. It is also the Chair of the Chinese Optical Instrument Committee and a constitutor of the International ISO Microscope standard.
Digital polymerase chain reaction (dPCR) is a biotechnological refinement of conventional polymerase chain reaction methods that can be used to directly quantify and clonally amplify nucleic acids strands including DNA, cDNA, or RNA.
GENE Optics is a leading manufacturer of precision optical instruments and optical components in China. It is also the Chair of the Chinese Optical Instrument Committee and a constitutor of the International ISO Microscope standard. The Company owns the brands “GENE”, “JIANGNAN”, and “NEXCOPE”.
Currently, we are also committed to the national project “Development and Industrialization of High-Resolution Fluorescence Microscopy”.Novel Optics has three production plants located in Ningbo, Nanjing and Zhenhai with a total of 1,200 employees.
GENE Optics is a leading manufacturer of precision optical instruments and optical components in China. It is also the Chair of the Chinese Optical Instrument Committee and a constitutor of the International ISO Microscope standard. The Company owns the brands “GENE”, “JIANGNAN”, and “NEXCOPE”.
GENE Optics is a leading manufacturer of precision optical instruments and optical components in China. It is also the Chair of the Chinese Optical Instrument Committee and a constitutor of the International ISO Microscope standard. The Company owns the brands “GENE”, “JIANGNAN”, and “NEXCOPE”.
DIAGNOSTIC SERVICES
Digital polymerase chain reaction (dPCR) is a biotechnological refinement of conventional polymerase chain reaction methods that can be used to directly quantify and clonally amplify nucleic acids strands including DNA, cDNA, or RNA. The key difference between dPCR and traditional PCR lies in the method of measuring nucleic acids amounts, with the former being a more precise method than PCR.
Combined with drug development needs, provide integrated solutions from clinical trial scheme consultation, patient recruitment, laboratory quality control molecular and immune biomarker detection services based on CAP, CLIA and ISO: 15189 certification, to final data mining. Through gene big data, GENE helps drug research and development, provides professional testing services for early research and development and target screening of drug users, and provides ideas and strong support for new drug research and development verification
Qualitative/quantitative detection of infectious pathogenic microorganisms (especially low-copy microorganisms), detection of mutation in pathogen resistance gene, pathogen typing and identification.
SYNTHETIC BIOLOGY
Tumor/cancer-related gene variation (mutation, fusion, methylation, CNV, etc.) for early cancer screening, companion diagnosis, targeted drug therapy, treatment guidance,
CELL THERAPY
Non-invasive prenatal screening, detection of neonatal genetic diseases such as congenital hypothyroidism and phenylketonuria.
MULTIGROUP RESEARCH
Qualitative/quantitative detection of infectious pathogenic microorganisms (especially low-copy microorganisms), detection of mutation in pathogen resistance gene, pathogen typing and identification.
SYNTHETIC BIOLOGY
Tumor/cancer-related gene variation (mutation, fusion, methylation, CNV, etc.) for early cancer screening, companion diagnosis, targeted drug therapy, treatment guidance, treatment efficacy monitoring and evaluation.
CELL THERAPY
Non-invasive prenatal screening, detection of neonatal genetic diseases such as congenital hypothyroidism and phenylketonuria.
MULTIGROUP RESEARCH
Qualitative/quantitative detection of infectious pathogenic microorganisms (especially low-copy microorganisms), detection of mutation in pathogen resistance gene, pathogen typing and identification.
SYNTHETIC BIOLOGY
Tumor/cancer-related gene variation (mutation, fusion, methylation, CNV, etc.) for early cancer screening, companion diagnosis, targeted drug therapy, treatment guidance, treatment efficacy monitoring and evaluation.
CELL THERAPY
Non-invasive prenatal screening, detection of neonatal genetic diseases such as congenital hypothyroidism and phenylketonuria.
